Skip to main content

Main Content

Jordan Introduced at Grand Rounds

On Friday, May 1, Dr. V. Craig Jordan spoke to nearly 150 faculty and staff in the Research Building Auditorium about his research entitled, “The Consequence of Exhaustive Antihormone Therapy: Estrogen Kills Breast Cancer Cells.” This is Jordan’s first Grand Rounds at GUMC.

Opening remarks were made by Lombardi’s director Louis Weiner, praising Jordan for his professional and medical achievements. “We are extraordinarily pleased to have Craig Jordan join Lombardi,” said Weiner. Jordan, who was recently accepted to the National Academy of Sciences, will begin his position as scientific director for the cancer center in July.

Acceptance to the National Academy of Sciences is one of the highest honors awarded to a scientist or engineer. “Dr. Jordan’s election to the National Academy of Sciences underscores his seminal contributions to the field of breast cancer therapy,” added Weiner.

During his presentation, Jordan highlighted the importance of tamoxifen, an anti-cancer drug. According to Jordan, tamoxifen revolutionized breast cancer treatment when it became the first drug proven to prevent cancer recurrence in women treated with adjuvant therapy for the disease. Eventually, tamoxifen became the first drug approved to reduce the risk of breast cancer in women at high risk of developing the disease. Jordan developed a related drug, raloxifene, several years later. Jordan stated that raloxifene is used both for the prevention of breast cancer and osteoporosis.

“Millions of women throughout the world have benefited from the application of this strategy,” said Jordan of his research. “Tamoxifen has saved the lives of over half a million women.” Following the presentation, a reception was held in the atrium of the New Research Building where colleagues and guests were invited to speak with Jordan.

Jordan comes to Lombardi from the Fox Chase Cancer Center in Philadelphia. To learn more about Craig Jordan and his research, please click here.

By Tressa Kirby, excerpted from the GUMC Update

(Published May 06, 2009)